| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.36 |
2e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-06 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
9e-06 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.31 |
2e-05 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |